Skip to Content

Join the 'Rasagiline' group to help and get support from people like you.

Rasagiline News

Brain Disconnects Spotted in Parkinson's Patients With Visual Hallucinations

Posted 28 Sep 2017 by Drugs.com

THURSDAY, Sept. 28, 2017 – Researchers say they've discovered a possible explanation for visual hallucinations in people with Parkinson's disease. The researchers conducted brain scans on 15 patients with visual hallucinations, 40 patients without visual hallucinations, and a control group of 15 people without Parkinson's disease. In all of the Parkinson's disease patients, numerous areas of the ...

Coffee Doesn't Help Parkinson's Motor Disorders

Posted 28 Sep 2017 by Drugs.com

THURSDAY, Sept. 28, 2017 – Regular cups of coffee will not ease tremors and movement problems caused by Parkinson's disease, despite prior evidence that caffeine might help, a new clinical trial reports. Earlier short-term results from the same trial had shown caffeine improved the motor function of a small group of Parkinson patients, researchers said. But long-term results from the trial now ...

Virtual House Calls for Speedy, Effective Parkinson's Care

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – Parkinson's disease patients get as much benefit from seeing a neurologist via home video conference as from seeing a local doctor in person, a new study reports. The research included nearly 200 patients who received either care from their usual doctor or their usual care plus up to four video (virtual) visits with a neurologist they had not seen before. The virtual ...

Singing May Be Good Medicine for Parkinson's Patients

Posted 12 Aug 2017 by Drugs.com

FRIDAY, Aug. 11, 2017 – Singing? To benefit people with Parkinson's disease? It just may help, a researcher says. "We're not trying to make them better singers, but to help them strengthen the muscles that control swallowing and respiratory function," said Elizabeth Stegemoller, an assistant professor of kinesiology at Iowa State University. Stegemoller holds a weekly singing therapy class for ...

White Collar Workers at Higher Odds of Death From ALS, Parkinson's

Posted 13 Jul 2017 by Drugs.com

THURSDAY, July 13, 2017 – Typically, better-paying jobs and those that require higher education are thought more desirable, but a new study suggests white collar workers have a higher risk of death from two neurodegenerative diseases. The research found that richer, better-educated people with Parkinson's disease or amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), appear ...

Exercise May Be Real Medicine for Parkinson's Disease

Posted 22 Dec 2016 by Drugs.com

THURSDAY, Dec. 22, 2016 – Almost any exercise is good medicine for someone with Parkinson's disease, a new study confirms. Although physical activity may seem impossible for some Parkinson's patients, the new research review reaffirms what many specialists already believe: that exercise can have a long-term impact, improving gait and reducing risk of falls, in particular. "I pretty much never ...

Exercise Benefits People With Parkinson's Disease: Study

Posted 24 Jun 2015 by Drugs.com

WEDNESDAY, June 24, 2015 – Parkinson's disease patients who begin regular exercise earlier have a much slower decline in quality of life than those who start exercising later, a new study finds. National Parkinson Foundation (NPF) researchers looked at information from nearly 3,000 patients. More than 1,300 reported doing little regular exercise before taking part in the study. Over two years, ...

Ex-Baseball Star Kirk Gibson Has Parkinson's Disease

Posted 28 Apr 2015 by Drugs.com

TUESDAY, April 28, 2015 – Kirk Gibson, who played 17 seasons of Major League Baseball and is perhaps best known for a dramatic pinch-hit, ninth inning home run to win a World Series game in 1988, said Tuesday he has Parkinson's disease. Gibson, 57, a Michigan native who played 12 seasons with the Detroit Tigers, said in a statement that "I have faced many different obstacles in my life, and have ...

FDA Approves Expanded Label for Azilect for Treatment Across All Stages of Parkinson’s Disease

Posted 11 Jun 2014 by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Jun. 9, 2014-- Teva Pharmaceutical Industries Ltd. today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Azilect (rasagiline tablets) from monotherapy and adjunct to levodopa (LD) to now include adjunct to dopamine agonists (DAs). The new indication reflects that Azilect can be used alone or in combination with other Parkinson’s d ...

Parkinson's Drugs Linked to Behavior Problems in Study

Posted 30 Mar 2011 by Drugs.com

TUESDAY, March 29 – Parkinson's disease drugs called dopamine agonists appear to cause impulse control problems in almost one-quarter of patients, says a new study. Previous research has linked dopamine agonists, which include Mirapex (pramipexole) and Requip (ropinirole), to impulse control disorders, such as gambling addiction and hypersexuality, and to compulsive behaviors, such as binge ...

New Parkinson's Drug Draws Mixed Reviews

Posted 16 Jul 2010 by Drugs.com

WEDNESDAY, Sept. 23 – A study to see whether a new drug can stop the progression of Parkinson's disease has produced results that have drawn sharply differing reactions from neurologists. The drug, rasagiline (Azilect), was approved in 2006 by the U.S. Food and Drug Administration on the basis of studies showing that it reduced Parkinson's symptoms such as trembling and slowed motion. The new ...

Parkinson's Drugs Tied to Compulsive Behaviors

Posted 10 May 2010 by Drugs.com

MONDAY, May 10 – Medicines used to treat Parkinson's disease may increase the risk of impulse control disorders, such as problem gambling, compulsive shopping and binge eating, researchers warn. In a new study that included 3,090 patients being treated for Parkinson's at 46 movement disorder centers in the United States and Canada, the researchers found that 13.6 percent of the patients had ...

Cutting Parkinson's Drug Dose Linked to Withdrawal Effects

Posted 14 Jan 2010 by Drugs.com

WEDNESDAY, Jan. 13 – Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in withdrawal, such as anxiety, panic attacks, pain, dizziness and drug cravings, researchers say. The symptoms of what the researchers have dubbed "dopamine agonist withdrawal syndrome" have been linked to a disruption in levels ...

FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions

Posted 15 Dec 2009 by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Dec 14, 2009 - Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for Azilect (rasagiline tablets) reducing medication and food restrictions. This update was based on clinical data that confirmed the mechanism of action of Azilect as a selective MAO-B (monoamine oxidase-B) ...

Ask a Question

Further Information

Related Condition Support Groups

Parkinson's Disease

Related Drug Support Groups

Azilect

Rasagiline Patient Information at Drugs.com